Webber, 2012, Outcomes of restrictive cardiomyopathy in childhood and the influence of phenotype. A report from the pediatric cardiomyopathy registry, Circulation, 126, 1237, 10.1161/CIRCULATIONAHA.112.104638
Otsuka, 2012, Prevalence and distribution of sarcomeric gene mutations in Japanese patients with familial hypertrophic cardiomyopathy, Circ J, 76, 453, 10.1253/circj.CJ-11-0876
Hayashi, 2018, Genetic background of Japanese patients with pediatric hypertrophic and restrictive cardiomyopathy, J Hum Genet, 63, 989, 10.1038/s10038-018-0479-y
Van Den Wijngaard, 2011, Recurrent and founder mutations in the Netherlands: cardiac troponin I (TNNI3) gene mutations as a cause of severe forms of hypertrophic and restrictive cardiomyopathy, Neth Heart J, 19, 344, 10.1007/s12471-011-0135-z
Mogensen, 2003, Idiopathic restrictive cardiomyopathy is part of the clinical expression of cardiac troponin I mutations, J Clin Invest, 111, 209, 10.1172/JCI200316336
Rai, 2009, Genetic and clinical profile of Indian patients of idiopathic restrictive cardiomyopathy with and without hypertrophy, Mol Cell Biochem, 331, 187, 10.1007/s11010-009-0157-7
Fujino, 2018, The TNNI3 Arg192His mutation in a 13-year-old girl with left ventricular noncompaction, J Cardiol Cases, 18, 33, 10.1016/j.jccase.2018.04.001
Richards, 2015, Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American college of medical genetics and genomics and the association for molecular pathology, Genet Med, 17, 405, 10.1038/gim.2015.30
Moon, 2005, Myocardial late gadolinium enhancement cardiovascular magnetic resonance in hypertrophic cardiomyopathy caused by mutations in troponin I, Heart, 91, 1036, 10.1136/hrt.2004.041384
Yumoto, 2005, Drastic Ca2+ sensitization of myofilament associated with a small structural change in troponin I in inherited restrictive cardiomyopathy, Biochem Biophys Res Commun, 338, 1519, 10.1016/j.bbrc.2005.10.116